Literature DB >> 3767074

Oral and dental complications of sickle cell disease in Nigerians.

L A Okafor, D C Nonnoo, P I Ojehanon, O Aikhionbare.   

Abstract

A clinical evaluation of the oral and dental complications of sickle cell disease in Nigerians was carried out in 37 consecutive patients with homozygous sickle cell disease Hb-SS (Sicklers) compared to a control group of 24 persons with normal haemoglobin Hb-AA (control group) matched for age and sex. The significant abnormalities found in sicklers included intrinsic opacity of the teeth in 67.5% of sicklers compared to 28.83% in the control group; malocclusion of the teeth with over-jet and over-bite in 35% of sicklers compared to 16.66% in the control group; dental caries is present in 35.13% of sicklers which was less than its occurrence in 54% of the control group due to widespread avoidance of sweets by most local sicklers. Diastemata (gaps between the teeth) was present in approximately equal frequency in sicklers (27%) and control group (25%). In view of the aesthetic and medical implications of these abnormalities, it is recommended that sicklers should receive regular dental check-up with a view to ameliorating or preventing these complications by prophylactic measures including the use of orthodontic appliances such as braces, etc. The above findings are discussed in relation to the other complications of sickler cell disease in other organs of the body.

Entities:  

Mesh:

Year:  1986        PMID: 3767074     DOI: 10.1177/000331978603700909

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  8 in total

1.  The association between sickle cell disease and dental caries in African Americans.

Authors:  Brian Laurence; David George; Dexter Woods; Adeyemisi Shosanya; Ralph V Katz; Sophie Lanzkron; Marie Diener-West; Neil Powe
Journal:  Spec Care Dentist       Date:  2006 May-Jun

2.  Acquisition of Streptococcus mutans and dental caries experience in pediatric sickle cell anaemia patients under various prophylactic therapies.

Authors:  S Hanumanta; R M Shetty; O Khandwal; S Rath; S Y Shetty; R K Diwan
Journal:  Eur Arch Paediatr Dent       Date:  2019-01-14

3.  The association between dental and periodontal diseases and sickle cell disease. A pilot case-control study.

Authors:  Haidar Al-Alawi; Abdulfatah Al-Jawad; Mahdi Al-Shayeb; Ali Al-Ali; Khalifa Al-Khalifa
Journal:  Saudi Dent J       Date:  2014-11-27

4.  Dental care provided to sickle cell anemia patients stratified by age: A population-based study in Northeastern Brazil.

Authors:  Cyrene Piazera Silva Costa; Bárbara Tamires Cruz Aires; Erika Bárbara Abreu Fonseca Thomaz; Soraia de Fátima Carvalho Souza
Journal:  Eur J Dent       Date:  2016 Jul-Sep

5.  Malocclusion and Craniofacial Characteristics in Saudi Adolescents with Sickle Cell Disease.

Authors:  Ahmed Basyouni; Naif Nasser Almasoud; Khalifa Sulaiman Al-Khalifa; Badr Abdulrahman Al-Jandan; Osama Abdulsalam Al Sulaiman; Muhammad Ashraf Nazir
Journal:  Saudi J Med Med Sci       Date:  2018-08-14

6.  Malocclusion and treatment need in children and adolescents with sickle cell disease.

Authors:  Ana Cláudia Alves e Luna; Fabiana Godoy; Valdenice Aparecida de Menezes
Journal:  Angle Orthod       Date:  2013-11-25       Impact factor: 2.079

7.  Craniofacial bone abnormalities and malocclusion in individuals with sickle cell anemia: a critical review of the literature.

Authors:  Cyrene Piazera Silva Costa; Halinna Larissa Cruz Correia de Carvalho; Erika Bárbara Abreu Fonseca Thomaz; Soraia de Fátima Carvalho Sousa
Journal:  Rev Bras Hematol Hemoter       Date:  2012

8.  Association between sickle cell disease and the oral health condition of children and adolescents.

Authors:  Carla Figueiredo Brandão; Viviane Maia Barreto Oliveira; Ada Rocha Ramony Martins Santos; Taísa Midlej Martins da Silva; Verônica Queiroz Cruz Vilella; Gleice Glenda Prata Pimentel Simas; Laura Regina Santos Carvalho; Raissa Aires Costa Carvalho; Ana Marice Teixeira Ladeia
Journal:  BMC Oral Health       Date:  2018-10-20       Impact factor: 2.757

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.